Talk:Macular edema

Edit request
April is posting on behalf of Alimera, and I am proposing this update to the approved treament section. --AprilE1234 (talk) 15:48, 28 June 2012 (UTC)

Iluvien
Iluvien, a sustained release intravitreal implant developed by Alimera Sciences, has been approved in Austria, Portugal and the U.K. for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. Additional EU country approvals are anticipated.


 * ✅ RudolfRed (talk) 03:01, 7 July 2012 (UTC)